首页> 外文期刊>European Journal of Pharmacology: An International Journal >Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
【24h】

Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.

机译:拉夫替丁是一种独特的组胺H2受体拮抗剂,它通过不依赖H2受体的机制抑制由扩张引起的胃酸分泌。

获取原文
获取原文并翻译 | 示例
       

摘要

Gastric acid secretion during the daytime has been implicated in the pathogenesis of acid-related diseases. Although daytime acid secretion is mainly governed by the parasympathetic vagal nerve, clinical observations have been accumulated that the H(2)-receptor antagonist lafutidine may have a strong effect. Here, we examined the actions of H(2)-receptor antagonists in a rat model of gastric acid secretion induced by stomach distention, a major post-meal stimulus. Indeed, the acid output during a 3h period after the instillation of saline into pylorus-ligated SD rats under urethane anesthesia was dependent on the instilled volume and was strongly suppressed by a vagotomy or the intraduodenal administration of atropine. Interestingly, lafutidine, but not famotidine or cimetidine, administered at a sufficient dose to block histamine-dependent acid secretion was capable of inhibiting distention-induced acid secretion. Moreover, gastric acid secretion induced by the intravenous perfusion of carbachol into SD rats was strongly inhibited by lafutidine but only partially inhibited by famotidine. The antisecretory action of lafutidine under these conditions was partly reversed by the co-administration of the nitric oxide synthase inhibitor L-NMMA, but was hardly affected by denervation with capsaicin or by the administration of the transient receptor potential channel V1 (TRPV1) antagonist capsazepine. Together with the observation that lafutidine increased the amount of intragastric nitric oxide, the present results suggest that lafutidine inhibits daytime gastric acid secretion not only by blocking H(2) receptors, but also through nitric oxide-mediated and histamine-independent indirect actions.
机译:白天的胃酸分泌与酸相关疾病的发病机制有关。虽然白天的酸分泌主要受副交感神经迷走神经支配,但临床观察表明,H(2)-受体拮抗剂拉夫替丁可能具有很强的作用。在这里,我们检查了H(2)受体拮抗剂在大鼠胃酸分泌引起的胃酸分泌模型中的作用,该模型是主要的餐后刺激。的确,在氨基甲酸乙酯麻醉下将盐水滴入幽门结扎的SD大鼠后3小时内的酸输出量取决于所滴入的量,并通过迷走神经切断术或十二指肠内给予阿托品来强烈抑制。有趣的是,以足以阻断组胺依赖性酸分泌的剂量施用拉夫替丁,而不是法莫替丁或西咪替丁,能够抑制扩张引起的酸分泌。此外,通过卡巴胆碱向SD大鼠静脉内灌注诱导的胃酸分泌受到拉夫替丁的强烈抑制,但仅受到法莫替丁的抑制。在这些条件下,拉夫替丁的抗分泌作用被一氧化氮合酶抑制剂L-NMMA的共同给药部分逆转,但几乎不受辣椒素去神经支配或通过瞬时受体电位通道V1(TRPV1)拮抗剂辣椒素的影响。连同拉夫替丁增加胃内一氧化氮的数量的观察结果,本结果表明拉夫替丁不仅通过阻断H(2)受体,而且通过一氧化氮介导的和组胺非依赖性的间接作用抑制白天胃酸分泌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号